Literature DB >> 22342864

N-3 polyunsaturated fatty acid supplementation does not reduce vulnerability to atrial fibrillation in remodeling atria.

Andrew Ramadeen1, Kim A Connelly, Howard Leong-Poi, Xudong Hu, Hiroko Fujii, Richard Van Krieken, Gabriel Laurent, Bruce J Holub, Richard P Bazinet, Paul Dorian.   

Abstract

BACKGROUND: Prophylactic supplementation with omega-3 polyunsaturated fatty acids (PUFAs) reduce vulnerability to atrial fibrillation (AF). The effect of PUFAs given after cardiac injury has occurred is unknown.
OBJECTIVE: To investigate using a model of pacing-induced cardiac injury, the time course of development of injury and whether it was altered by postinjury PUFAs.
METHODS: Sixty-five dogs were randomized to undergo simultaneous atrial and ventricular pacing (SAVP, 220 beats/min) for 0, 2, 7, or 14 days. Twenty-two dogs received PUFAs (850 mg/d) either prophylactically or after some pacing had occurred (postinjury). Electrophysiologic and echocardiographic measurements were taken at baseline and sacrifice. Atrial tissue samples were collected at sacrifice for histologic and molecular analyses.
RESULTS: With no PUFAs, the inducibility of AF increased with pacing duration (P < .001). Postinjury PUFAs (started after 7 days of pacing) did not reduce the inducibility of AF after 14 days of pacing (9.3% ± 8.8% no PUFAs vs 9.7% ± 9.9% postinjury PUFAs; P = .91). Atrial myocyte size and fibrosis increased with pacing duration (P < .05). Postinjury PUFAs did not significantly attenuate the cell size increase after 14 days of pacing (no PUFAs 38% ± 30% vs postinjury PUFAs 19% ± 28%; P = .11). Similarly, postinjury PUFAs did not attenuate the increase in fibrosis after 14 days of pacing (no PUFAs 66% ± 51% vs postinjury PUFAs 63% ± 76%; P = .90).
CONCLUSION: PUFA supplementation begun after cardiac injury has already occurred does not reduce atrial structural remodeling or vulnerability to AF.
Copyright © 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22342864     DOI: 10.1016/j.hrthm.2012.02.013

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  8 in total

1.  Fish oil for atrial fibrillation prevention: can we intervene soon enough to make a difference?

Authors:  David R Van Wagoner
Journal:  Heart Rhythm       Date:  2012-03-07       Impact factor: 6.343

Review 2.  Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation.

Authors:  Rajeev Pathak; Dennis H Lau; Rajiv Mahajan; Prashanthan Sanders
Journal:  J Atr Fibrillation       Date:  2013-12-31

Review 3.  Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.

Authors:  Jeffrey J Goldberger; Rishi Arora; David Green; Philip Greenland; Daniel C Lee; Donald M Lloyd-Jones; Michael Markl; Jason Ng; Sanjiv J Shah
Journal:  Circulation       Date:  2015-07-28       Impact factor: 29.690

4.  Upstream Treatment of Atrial Fibrillation with n-3 Polyunsaturated Fatty Acids: Myth or Reality?

Authors:  Francesco Orso; Gianna Fabbri; Aldo Pietro Maggioni
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-12-01

5.  Axial tubule junctions control rapid calcium signaling in atria.

Authors:  Sören Brandenburg; Tobias Kohl; George S B Williams; Konstantin Gusev; Eva Wagner; Eva A Rog-Zielinska; Elke Hebisch; Miroslav Dura; Michael Didié; Michael Gotthardt; Viacheslav O Nikolaev; Gerd Hasenfuss; Peter Kohl; Christopher W Ward; W Jonathan Lederer; Stephan E Lehnart
Journal:  J Clin Invest       Date:  2016-09-19       Impact factor: 14.808

6.  Omega-3 Fatty acids: anti-arrhythmic, pro-arrhythmic, or both?

Authors:  C von Schacky
Journal:  Front Physiol       Date:  2012-04-17       Impact factor: 4.566

7.  How Are n-3 LCPUFAs Antiarrhythmic? A Reassessment of n-3 LCPUFAs in Cardiac Disease.

Authors:  Andrew Ramadeen; Paul Dorian
Journal:  Cardiol Res Pract       Date:  2012-08-16       Impact factor: 1.866

Review 8.  The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation.

Authors:  Georgios A Christou; Konstantinos A Christou; Panagiotis Korantzopoulos; Evangelos C Rizos; Dimitrios N Nikas; John A Goudevenos
Journal:  Int J Mol Sci       Date:  2015-09-22       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.